Treatment of Heart Failure: The Multiplication of Therapeutic Means

James L. Januzzi, MD

December 09, 2022

James L. Januzzi, MD, contemplates the astonishing advances in therapeutics for heart failure that have occurred over recent decades.

From the established use of ACE inhibitors to the current development of SGLT2 inhibitors, Dr Januzzi marvels at the efflorescence of means available to the clinician to provide the most effective care for patients.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Treatment of Heart Failure: The Multiplication of Therapeutic Means - Medscape - Dec 09, 2022.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Need a Curbside Consult? Share cases and questions with Physicians on Medscape Consult. Share a Case

Treatment of Heart Failure: The Multiplication of Therapeutic Means

Tables

Authors and Disclosures

Authors and Disclosures

Expert

James L. Januzzi, MD

Comments

Email This

Feedback